The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 399-406

  Martinez Martin, Pablo ^a,b   Rodriguez Blazquez, Carmen ^a   Kurtis, Monica M ^c   Chaudhuri, K Ray ^d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Unidad Radiocirugia   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Assessment; EQ 5D; Health related quality of life; Non motor symptoms scale; Non motor symptoms; Parkinson's disease; Parkinson's disease questionnaire 39 items

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DELUSION; DIPLOPIA; DIZZINESS; DYSPHAGIA; EQ 5D; FATIGUE; FEMALE; HALLUCINATION; HOEHN AND YAHR STAGING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOCTURIA; NON MOTOR SYMPTOM SCALE; PAIN; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39 ITEMS; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RESTLESS LEGS SYNDROME; SALIVATION DISORDER; SCOPA MOTOR; SCORING SYSTEM; SLEEP DISORDER; SWEAT GLAND DISEASE; SYNCOPE; WEIGHT CHANGE;

AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL DISEASES; HEALTH STATUS; HUMANS; INTERNATIONAL COOPERATION; LINEAR MODELS; MALE; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; PSYCHOMETRICS; QUALITY OF LIFE; RESPIRATORY TRACT DISEASES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; UROLOGIC DISEASES;

EID: 79953276342     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23462     Document Type: Article

References (41)

1. Martinez-Martin P. An introduction to the concept of "quality of life in Parkinson's disease." J Neurol 1998; 245( Suppl 1): S2-S6.
2. Grosset KA, Grosset DG. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life. Mov Disord 2005; 20: 616-619.
3. Karlsen KH, Larsen JP, Tandberg E, Maland JG. Quality of life measurements in patients with Parkinson's disease: A community-based study. Eur J Neurol 1998; 5: 443-450.
4. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F. Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 2003; 24: 209-210.
5. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005; 20: 224-230.
6. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66: 431-435.
7. Klepac N, Pikija S, Kraljic T, et al. Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross-sectional study in Croatia. Eur J Neurol 2007; 14: 194-198.
8. Ray J, Das SK, Gangopadhya PK, Roy T. Quality of life in Parkinson's disease-Indian scenario. J Assoc Physicians India 2006; 54: 17-21.
9. Zhao YJ, Tan LC, Lau PN, Au WL, Li SC, Luo N. Factors affecting health-related quality of life amongst Asian patients with Parkinson's disease. Eur J Neurol 2008; 15: 737-742.
10. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-197.
11. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 697-701.
12. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006; 21: 916-923.
13. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007; 22: 1901-1911.
14. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009; 73: 1584-1591.
15. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
16. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208.
17. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997; 26: 353-357.
18. Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics 1998; 13: 687-696.
19. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 67-73.
20. Grosset D, Taurah L, Burn DJ, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 2007; 78: 465-469.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
22. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004; 75: 388-395.
23. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-312.
24. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials, Second ed. Philadelphia: Lippincott-Raven Publishers; 1996. p 49-56.
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289-300.
26. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001; 92: 76-85.
27. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
28. Wullner U, Schmitz-Hubsch T, Antony G, et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. Eur J Neurol 2007; 14: 1405-1408.
29. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007; 69: 333-341.
30. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008; 23: 101-106.
31. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008; 23: 1428-1434.
32. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-1629.
33. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters. Neurourol Urodyn 2009; 28: 510-515.
34. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
35. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148.
36. Honig H, Antonini A, Martinez-Martin P, et al. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009; 24: 1468-1474.
37. Martinez-Martin P, Catalan MJ, Benito-Leon J, et al. Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006; 15: 597-606.
38. Herlofson K, Larsen JP. The influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand 2003; 107: 1-6.
39. Qin Z, Zhang L, Sun F, et al. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009; 15: 767-771.
40. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord 2008; 23: 653-659.
41. Celikel E, Ozel-Kizil ET, Akbostanci MC, Cevik A. Assessment of sexual dysfunction in patients with Parkinson's disease: a case-control study. Eur J Neurol 2008; 15: 1168-1172.